• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服葡萄糖和静脉注射胰高血糖素后胰腺β细胞的分泌:新诊断的非胰岛素依赖型糖尿病患者对血糖饮食控制的不同反应。

Pancreatic beta-cell secretion after oral glucose and intravenous glucagon: different responses to dietary control of plasma glucose in newly diagnosed patients with NIDDM.

作者信息

Hsieh S D, Iwamoto Y, Matsuda A, Kuzuya T

出版信息

Metabolism. 1987 Apr;36(4):384-7. doi: 10.1016/0026-0495(87)90212-5.

DOI:10.1016/0026-0495(87)90212-5
PMID:3550376
Abstract

Pancreatic beta-cell secretion after oral glucose or intravenous glucagon stimulation was studied in newly diagnosed patients with non-insulin-dependent diabetes mellitus (NIDDM) before and after glycemic control by diet treatment alone. Insulin secretion to oral glucose showed significant improvement, while C-peptide release by glucagon showed no significant difference before and after diet treatment. The finding suggests that pancreatic beta-cell response to oral glucose varies with different metabolic states, but this is not so after glucagon stimulation in NIDDM patients.

摘要

在仅通过饮食治疗实现血糖控制前后,对新诊断的非胰岛素依赖型糖尿病(NIDDM)患者口服葡萄糖或静脉注射胰高血糖素刺激后的胰腺β细胞分泌情况进行了研究。口服葡萄糖后的胰岛素分泌有显著改善,而饮食治疗前后胰高血糖素刺激后的C肽释放无显著差异。这一发现表明,胰腺β细胞对口服葡萄糖的反应随不同代谢状态而变化,但在NIDDM患者中,胰高血糖素刺激后并非如此。

相似文献

1
Pancreatic beta-cell secretion after oral glucose and intravenous glucagon: different responses to dietary control of plasma glucose in newly diagnosed patients with NIDDM.口服葡萄糖和静脉注射胰高血糖素后胰腺β细胞的分泌:新诊断的非胰岛素依赖型糖尿病患者对血糖饮食控制的不同反应。
Metabolism. 1987 Apr;36(4):384-7. doi: 10.1016/0026-0495(87)90212-5.
2
Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.高碳水化合物摄入量对非胰岛素依赖型糖尿病患者高血糖、胰岛功能及血浆脂蛋白的影响。
Diabetes Care. 1992 Nov;15(11):1572-80. doi: 10.2337/diacare.15.11.1572.
3
Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.环境血糖水平和肥胖程度对非胰岛素依赖型糖尿病患者基础血清C肽水平以及C肽对葡萄糖和胰高血糖素反应的差异影响。
Diabetes Res Clin Pract. 1997 Sep;37(3):165-71. doi: 10.1016/s0168-8227(97)00069-7.
4
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.通过对非胰岛素依赖型糖尿病患者夜间输注胰高血糖素样肽1(7-36)酰胺使胰岛素对葡萄糖的反应正常化。
Diabetes. 1996 Nov;45(11):1524-30. doi: 10.2337/diab.45.11.1524.
5
Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.首阶段胰岛素反应受损可预测新诊断2型糖尿病患者的餐后血糖升高。
Scand J Clin Lab Invest. 2007;67(3):327-36. doi: 10.1080/00365510601124024.
6
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.使用胰高血糖素样肽-1评估β细胞分泌能力。
Diabetes Care. 2000 Jun;23(6):807-12. doi: 10.2337/diacare.23.6.807.
7
The effect of chronic hyperglycaemia on the islet B-cell responsiveness in newly diagnosed type 2 diabetes.慢性高血糖对新诊断2型糖尿病患者胰岛B细胞反应性的影响。
Diabet Med. 1992 Aug-Sep;9(7):601-4. doi: 10.1111/j.1464-5491.1992.tb01853.x.
8
Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.胰高血糖素样肽1可改善糖耐量受损患者β细胞感知和响应葡萄糖的能力。
Diabetes. 1998 Aug;47(8):1259-65. doi: 10.2337/diab.47.8.1259.
9
Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.在非胰岛素依赖型糖尿病发病机制中,胰岛素分泌受损比内脏脂肪增多出现得更早。对最初无糖尿病的日裔美国男性进行的5年随访。
Diabetes Care. 1995 Jun;18(6):747-53. doi: 10.2337/diacare.18.6.747.
10
Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
Diabetes Res Clin Pract. 1992 Nov;18(2):99-105. doi: 10.1016/0168-8227(92)90005-c.